CS Diagnostics Corp. CSDX
Set alert
0.01 USD 0.00 0.00%
At close · Oct 30
0.07 Day range 0.07
0.0004 52-week range 0.40
- YTD
- -97.61%
- 1 year
- -97.97%
- Open
- 0.07
- Prev close
- 0.0073
- Mkt cap
- 1.82M
- Vol
- 100
- Avg vol
- 3.85K
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.07
- High
- 0.07
6M chart
Signals (15)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 9, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 25, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 15, 2026 | 1 month ago |
| RSI: Oversold | Sep 14, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 3, 2026 | 1 month ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
| RSI: Oversold | Aug 18, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Jul 24, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 26, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 17, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 9, 2026 | 4 months ago |
| MACD: Sell Signal | May 15, 2026 | 5 months ago |
| MACD: Buy Signal | May 14, 2026 | 5 months ago |
| MACD: Sell Signal | May 7, 2026 | 5 months ago |
News
- CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH
- CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH
- CS Group (OTCQB: CSDX) Secures Strategic Manufacturing Partnerships, Accelerating Global Commercial Launch of MEDUSA SDP Hygiene Products
- CS Group (OTCQB: CSDX) Secures Strategic Manufacturing Partnerships, Accelerating Global Commercial Launch of MEDUSA SDP Hygiene Products
- CS Group (OTCQB: CSDX) Announces Multi-Channel Sales Model, Global Logistics Partners, and Sustainable Innovation Roadmap for MEDUSA SDP
- CS Group (OTCQB: CSDX) Announces Multi-Channel Sales Model, Global Logistics Partners, and Sustainable Innovation Roadmap for MEDUSA SDP
- CS Diagnostics Corp. Launches Regulation D, Rule 506(c) Investment Offering
- CS Diagnostics Corp. (OTCQB: CSDX) Accelerates Global Expansion with Key Regulatory Milestones and Record Growth
- CS Diagnostics Corp. Submits Patent Application For CS-Protect Hydrogel in the US Market
- CS Diagnostics Corp. Submitted Final Form-10 Registration Statement Draft to the processing team for preparation of Edgardization and filing with the U.S. Securities and Exchange Commission ("SEC")
Your note
Sign in to keep a note on CSDX — it syncs with the Stock Master app.